Showing results (1601-1610 of 4,133) with videos related to
Sort By:
Pageof 414
The Journal of Allergy and Clinical Immunology|January 1, 1977
Harvester ant sensitivity: in vitro and in vivo studies using whole body extracts and venomJ L Pinnas, R C Strunk, T M Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Elevated caveolin-1 levels in African-American versus white-American prostate cancerG Yang, J Addai, M Ittmann, et al.Neurosurgery|July 22, 1999
Direct and combined revascularization in pediatric moyamoya diseaseA J Golby, M P Marks, R C Thompson, et al.Psychopharmacology|June 27, 2000
Effects of the nicotinic antagonist mecamylamine on inspection timeJ C Thompson, C Stough, D Ames, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 30, 2000
The effects of nicotine on the 13 Hz steady-state visually evoked potentialJ C Thompson, K Tzambazis, C Stough, et al.Oncogene|December 26, 2001
LAPSER1: a novel candidate tumor suppressor gene from 10q24.3Y Cabeza-Arvelaiz, T C Thompson, J L Sepulveda, et al.Surgery, Gynecology & Obstetrics|May 1, 1975
Natural history and experience with diagnosis and treatment of the Zollinger-Ellison syndromeJ C Thompson, D D Reeder, H V Villar, et al.International Journal for Parasitology|June 29, 2001
Complete development and long-term maintenance of Cryptosporidium parvum human and cattle genotypes in cell cultureN S Hijjawi, B P Meloni, U M Morgan, et al.Antimicrobial Agents and Chemotherapy|July 18, 2002
Hexapeptide derivatives of glycopeptide antibiotics: tools for mechanism of action studiesNorris E Allen, Deborah L LeTourneau, Joe N Hobbs, et al.Biochemical Pharmacology|October 26, 1995
HPLC and 31P NMR characterization of the reaction between antitumor platinum agents and the phosphorothioate chemoprotective agent S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721)D C Thompson, S D Wyrick, D J Holbrook, et al.Pageof 414